| Three galactose inducible promoters for use in C. neoformans var. grubii. Ruff J.A., Lodge J.K., Baker L.G.
Fungal Genet. Biol. 46:9-16(2009) · Mapped (3) |
| A chitin synthase and its regulator protein are critical for chitosan production and growth of the fungal pathogen Cryptococcus neoformans. Banks I.R., Specht C.A., Donlin M.J., Gerik K.J., Levitz S.M., Lodge J.K.
Eukaryotic Cell 4:1902-1912(2005) · Mapped (1) |
| Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. Gerik K.J., Donlin M.J., Soto C.E., Banks A.M., Banks I.R., Maligie M.A., Selitrennikoff C.P., Lodge J.K.
Mol. Microbiol. 58:393-408(2005) · Mapped (8) |
| Noncompetitive plasma biokinetics of deuterium-labeled natural and synthetic alpha-tocopherol in healthy men with an apoE4 genotype. Proteggente A.R., Turner R., Majewicz J., Rimbach G., Minihane A.M., Kramer K., Lodge J.K.
J. Nutr. 135:1063-1069(2005) · Mapped (5) |
| Thioredoxin reductase is essential for viability in the fungal pathogen Cryptococcus neoformans. Missall T.A., Lodge J.K.
Eukaryotic Cell 4:487-489(2005) · UniProtKB (1) |
| The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans. Loftus B.J., Fung E., Roncaglia P., Rowley D., Amedeo P., Bruno D., Vamathevan J., Miranda M., Anderson I.J., Fraser J.A. et al.
Science 307:1321-1324(2005) · UniProtKB (6,438) |
| Distinct stress responses of two functional laccases in Cryptococcus neoformans are revealed in the absence of the thiol-specific antioxidant Tsa1. Missall T.A., Moran J.M., Corbett J.A., Lodge J.K.
Eukaryotic Cell 4:202-208(2005) · UniProtKB (2) |
| Thiol peroxidase is critical for virulence and resistance to nitric oxide and peroxide in the fungal pathogen, Cryptococcus neoformans. Missall T.A., Pusateri M.E., Lodge J.K.
Mol. Microbiol. 51:1447-1458(2004) · UniProtKB (2) |
| Identification of virulence mutants of the fungal pathogen Cryptococcus neoformans using signature-tagged mutagenesis. Nelson R.T., Hua J., Pryor B., Lodge J.K.
Genetics 157:935-947(2001) · UniProtKB (1) |
| Genetic and biochemical studies establish that the fungicidal effect of a fully depeptidized inhibitor of Cryptococcus neoformans myristoyl-CoA:protein N-myristoyltransferase (Nmt) is Nmt-dependent. Lodge J.K., Jackson-Machelski E., Higgins M., McWherter C.A., Sikorski J.A., Devadas B., Gordon J.I.
J. Biol. Chem. 273:12482-12491(1998) · Mapped (1) |
| N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase. Lodge J.K., Jackson-Machelski E., Devadas B., Zupec M.E., Getman D.P., Kishore N., Freeman S.K., McWherter C.A., Sikorski J.A., Gordon J.I.
Microbiology (Reading, Engl.) 143:357-366(1997) · Mapped (2) |
| Comparison of myristoyl-CoA:protein N-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans. Lodge J.K., Johnson R.L., Weinberg R.A., Gordon J.I.
J. Biol. Chem. 269:2996-3009(1994) · UniProtKB (6) · Mapped (3) |
| 4-oxatetradecanoic acid is fungicidal for Cryptococcus neoformans and inhibits replication of human immunodeficiency virus I. Langner C.A., Lodge J.K., Travis S.J., Caldwell J.E., Lu T., Li Q., Bryant M.L., Devadas B., Gokel G.W., Kobayashi G.S.
J. Biol. Chem. 267:17159-17169(1992) · UniProtKB (1) · Mapped (2) |